BlackRock Fund Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$166M Buy
4,137,423
+520,761
+14% +$19.6M 0.03% 796
2016
Q3
$131M Buy
3,616,662
+284,894
+9% +$9.78M 0.03% 873
2016
Q2
$96.6M Buy
3,331,768
+95,124
+3% +$2.88M 0.02% 1004
2016
Q1
$113M Sell
3,236,644
-1,399
-0% -$45.2K 0.03% 852
2015
Q4
$104M Buy
3,238,043
+176,583
+6% +$5.73M 0.02% 920
2015
Q3
$98.9M Buy
3,061,460
+41,660
+1% +$1.57M 0.03% 912
2015
Q2
$125M Sell
3,019,800
-35,127
-1% -$1.48M 0.03% 805
2015
Q1
$137M Buy
3,054,927
+160,425
+6% +$6.71M 0.03% 729
2014
Q4
$108M Buy
2,894,502
+250,882
+9% +$9.19M 0.03% 881
2014
Q3
$92.3M Sell
2,643,620
-84,707
-3% -$3.02M 0.03% 896
2014
Q2
$96.3M Sell
2,728,327
-164,196
-6% -$5.48M 0.03% 911
2014
Q1
$94.3M Buy
2,892,523
+55,463
+2% +$2.12M 0.03% 892
2013
Q4
$120M Buy
2,837,060
+71,312
+3% +$2.93M 0.04% 699
2013
Q3
$110M Buy
2,765,748
+317,214
+13% +$13.3M 0.04% 675
2013
Q2
$101M Buy
+2,448,534
New +$99.1M 0.04% 651

Other funds holding HAE

BlackRock Fund Advisors's HAE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Haemonetics (HAE) stake by 14% in Q4 2016, buying an estimated $19.6M and bringing the position to 4,137,423 shares worth $166M. The position accounts for 0.03% of the portfolio, ranked #796.

BlackRock Fund Advisors first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. 198 funds tracked by Wall St. Rank hold HAE as of Q4 2016.

  • BlackRock Fund Advisors held 4,137,423 shares of Haemonetics worth $166M as of Q4 2016.
  • BlackRock Fund Advisors bought 520,761 Haemonetics shares in Q4 2016, an estimated $19.6M.
  • Haemonetics made up 0.03% of BlackRock Fund Advisors's portfolio in Q4 2016, its #796 holding.
  • BlackRock Fund Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
  • 198 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.